SAFLUTAN 4.5 MCG / 0.3 ML
TAFLUPROST : 4.5 MCG / 0.3 ML · DIN 02425149 · PURDUE PHARMA
Health Canada status: CANCELLED PRE MARKET
What is SAFLUTAN?
SAFLUTAN 4.5 MCG / 0.3 ML contains TAFLUPROST : 4.5 MCG / 0.3 ML. It is listed in the Health Canada Drug Product Database under DIN 02425149, held by PURDUE PHARMA, supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as cancelled pre market, status dated 18-May-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02425149 |
|---|---|
| Brand name | SAFLUTAN |
| Generic / active ingredient | TAFLUPROST : 4.5 MCG / 0.3 ML |
| Manufacturer | PURDUE PHARMA |
| Strength | 4.5 MCG / 0.3 ML |
| Dosage form | SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01EE05 TAFLUPROST |
| AHFS class | 52:40.28 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 18-May-2023 |
Who else supplies TAFLUPROST worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TAFLUPROST appears in 15 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.